Lv3
240 积分 2021-02-23 加入
Industry's perspective on challenges assessing the in vivo impact of removing titanium dioxide (TiO2) from drug products
4天前
求助中
Nitrosamine formation in lidocaine active pharmaceutical ingredients and drug products
11天前
已完结
Construction of a modified Arrhenius equation for predicting drug nitrosation in solid dosage form
11天前
已完结
An Overview of Pharmaceutical Excipients: Safe or Not Safe?
13天前
已完结
P18-78 What does new nitrosamine data reveal about the CPCA framework?
20天前
已完结
The Presence of Nitrosamines and Nitrosamine Drug-Related Substances in Pharmaceutical Products: An Overview of Regulatory Concerns, Analytical Methodologies, and Control Strategies
20天前
已完结
Evaluating change during pharmaceutical product development and manufacture—comparability and equivalence
20天前
已完结
The Nitrite-Amines Nexus in Nitrosamine Formation: Mechanisms, Mutagenic Implications, Regulations, and Root Causes in Medicines
20天前
已完结
Navigating ICH Q2(R2) Compliance in Analytical Method Validation: A Gap Analysis Toolkit to Streamline Risk Assessment and Change Management
1个月前
已关闭
Stability-indicating method development for quantification of bromopride, its impurities, and degradation products by ultra-high performance liquid chromatography applying Analytical Quality by Design principles
1个月前
已完结
皖公网安备34019202002308
